Mark A. Goldsmith, See Remarks at Revolution Medicines, Inc. (RVMD), sold 13,988 shares at $195.01 ($2.8M) on 2026-09-16, disclosed to the SEC on 2026-09-18.
Scheduled sale ($2.8M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $195.01 | 213 | $42K | 1.5% |
| 2 | $199.30 | 13,775 | $2.7M | 98.5% |
| Total | $199.24 avg | 13,988 | $2.8M | 100% |
| Filing → |
| RVMD | SELL | 2026-04-17 | $18.0M | — | Filing → |
| RVMD | SELL | 2026-03-19 | $2.6M | — | Filing → |
| RVMD | SELL | 2026-03-03 | $7.2M | — | Filing → |